CRT 23 Late-Breaking Science Video Collection

Published: 17 March 2023

  • Views:

    Views Icon 264
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating


For short, concise coverage of the key data released at CRT 2023, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research. 

About the episode

CRT 23 - In this short interview, we are joined by Dr Jose De La Torre Hernandez (Hospital Universitario Marques de Valdecilla, ES) to provide an update on the OPTIMAL Randomized Controlled Trial, sponsored by the European Cardiovascular Institute. In this ongoing study, 800 patients will be randomized to receive either intravascular ultrasound-guided percutaneous coronary intervention (PCI) or qualitative angiography-guided PCI for the treatment of left main coronary stenosis. 


1. What was the rationale behind this study?
2. What was the patient population, current enrollment status and study design?
3. What is the potential impact of the results of this trial?
5. What are the next steps for OPTIMAL?

Recorded remotely from Santander, 2023. 

Editor: Jordan Rance

Videography: Dan Brent and Oliver Miles.

Faculty Biographies

José M de la Torre Hernández

José M de la Torre Hernández

Head of Hemodynamics and Interventional Cardiology

Prof Jose M de la Torre is an interventional cardiologist and Head of the Hemodynamics and Interventional Department of the Marques de Valdecilla University of Santander, ES.

Prof Jose M de la Torre is member of the scientific committee of the Spanish Society of Cardiology and is fellow of the European Society of Cardiology. Former associate director of the Trans Catheter Therapeutics Meeting in US. Faculty of ESC, PCR, ACC and TCT meetings. Coordinator of the ESTROFA, XIMA and LITRO study groups. 


View full profile


You must be to comment. If you are not registered, you can register here.